NCT00957957 Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134) Status COMPLETED Phase N/A
NCT00957190 The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) Status COMPLETED Phase PHASE4
NCT00954993 Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029) Status TERMINATED Phase PHASE1
NCT00954538 Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001) Status COMPLETED Phase PHASE1
NCT00954512 Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Status TERMINATED Phase PHASE1/PHASE2
NCT00953056 A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00952341 Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00948688 Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas Status TERMINATED Phase PHASE1/PHASE2
NCT00948064 Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00947011 Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1) Status TERMINATED Phase PHASE2
NCT00945750 A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144) Status COMPLETED Phase PHASE1
NCT00945321 A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) Status COMPLETED Phase PHASE1
NCT00944450 Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027) Status COMPLETED Phase PHASE1
NCT00943761 A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028) Status COMPLETED Phase PHASE2
NCT00943722 A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) Status COMPLETED Phase PHASE3
NCT00943371 A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002) Status TERMINATED Phase PHASE1